These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 33775738)

  • 21. Antinociceptive properties of an isoform-selective inhibitor of Nav1.7 derived from saxitoxin in mouse models of pain.
    Beckley JT; Pajouhesh H; Luu G; Klas S; Delwig A; Monteleone D; Zhou X; Giuvelis D; Meng ID; Yeomans DC; Hunter JC; Mulcahy JV
    Pain; 2021 Apr; 162(4):1250-1261. PubMed ID: 33086288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent advances in small molecule Nav 1.7 inhibitors for cancer pain management.
    Yu X; Zhao X; Li L; Huang Y; Cui C; Hu Q; Xu H; Yin B; Chen X; Zhao D; Qiu Y; Hou Y
    Bioorg Chem; 2024 Sep; 150():107605. PubMed ID: 38971095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial.
    de Greef BTA; Hoeijmakers JGJ; Geerts M; Oakes M; Church TJE; Waxman SG; Dib-Hajj SD; Faber CG; Merkies ISJ
    Brain; 2019 Feb; 142(2):263-275. PubMed ID: 30649227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-96 is required to prevent allodynia by repressing voltage-gated sodium channels in spinal cord.
    Sun L; Xia R; Jiang J; Wen T; Huang Z; Qian R; Zhang MD; Zhou M; Peng C
    Prog Neurobiol; 2021 Jul; 202():102024. PubMed ID: 33636225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Network topology of NaV1.7 mutations in sodium channel-related painful disorders.
    Kapetis D; Sassone J; Yang Y; Galbardi B; Xenakis MN; Westra RL; Szklarczyk R; Lindsey P; Faber CG; Gerrits M; Merkies IS; Dib-Hajj SD; Mantegazza M; Waxman SG; Lauria G;
    BMC Syst Biol; 2017 Feb; 11(1):28. PubMed ID: 28235406
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nav1.7 and other voltage-gated sodium channels as drug targets for pain relief.
    Emery EC; Luiz AP; Wood JN
    Expert Opin Ther Targets; 2016 Aug; 20(8):975-83. PubMed ID: 26941184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Novel SCN9A Mutation (F826Y) in Primary Erythromelalgia Alters the Excitability of Nav1.7.
    Wu B; Zhang Y; Tang H; Yang M; Long H; Shi G; Tang J; Shi X
    Curr Mol Med; 2017; 17(6):450-457. PubMed ID: 28990532
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Novel Activity of Carbamazepine as an Activation Modulator Extends from Na
    Han C; Themistocleous AC; Estacion M; Dib-Hajj FB; Blesneac I; Macala L; Fratter C; Bennett DL; Waxman SG; Dib-Hajj SD
    Mol Pharmacol; 2018 Nov; 94(5):1256-1269. PubMed ID: 30135145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the Spider (
    Gonçalves TC; Lesport P; Kuylle S; Stura E; Ciolek J; Mourier G; Servent D; Bourinet E; Benoit E; Gilles N
    Toxins (Basel); 2019 Aug; 11(9):. PubMed ID: 31443554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of WB4101, an
    Li M; Wu Y; Zou B; Wang X; Li M; Yu H
    Mol Pharmacol; 2018 Aug; 94(2):896-906. PubMed ID: 29884692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel SCN9A mutations underlying extreme pain phenotypes: unexpected electrophysiological and clinical phenotype correlations.
    Emery EC; Habib AM; Cox JJ; Nicholas AK; Gribble FM; Woods CG; Reimann F
    J Neurosci; 2015 May; 35(20):7674-81. PubMed ID: 25995458
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective Closed-State Nav1.7 Blocker JZTX-34 Exhibits Analgesic Effects against Pain.
    Zeng X; Li P; Chen B; Huang J; Lai R; Liu J; Rong M
    Toxins (Basel); 2018 Feb; 10(2):. PubMed ID: 29393892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of the neuronal sodium channel Na
    Bengel P; Ahmad S; Tirilomis P; Trum M; Dybkova N; Wagner S; Maier LS; Hasenfuß G; Sossalla S
    J Mol Cell Cardiol; 2020 Jul; 144():35-46. PubMed ID: 32418916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain without nociceptors? Nav1.7-independent pain mechanisms.
    Minett MS; Falk S; Santana-Varela S; Bogdanov YD; Nassar MA; Heegaard AM; Wood JN
    Cell Rep; 2014 Jan; 6(2):301-12. PubMed ID: 24440715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-30b regulates expression of the sodium channel Nav1.7 in nerve injury-induced neuropathic pain in the rat.
    Shao J; Cao J; Wang J; Ren X; Su S; Li M; Li Z; Zhao Q; Zang W
    Mol Pain; 2016; 12():. PubMed ID: 27765894
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat.
    Rahman W; Dickenson AH
    Neuroscience; 2015 Jun; 295():103-16. PubMed ID: 25818052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders.
    Yuan JH; Cheng X; Matsuura E; Higuchi Y; Ando M; Hashiguchi A; Yoshimura A; Nakachi R; Mine J; Taketani T; Maeda K; Kawakami S; Kira R; Tanaka S; Kanai K; Dib-Hajj F; Dib-Hajj SD; Waxman SG; Takashima H
    J Peripher Nerv Syst; 2023 Dec; 28(4):597-607. PubMed ID: 37555797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Na
    Wimalasena NK; Taub DG; Shim J; Hakim S; Kawaguchi R; Chen L; El-Rifai M; Geschwind DH; Dib-Hajj SD; Waxman SG; Woolf CJ
    Exp Neurol; 2023 Jun; 364():114393. PubMed ID: 37003485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The discovery of benzoxazine sulfonamide inhibitors of Na
    La DS; Peterson EA; Bode C; Boezio AA; Bregman H; Chu-Moyer MY; Coats J; DiMauro EF; Dineen TA; Du B; Gao H; Graceffa R; Gunaydin H; Guzman-Perez A; Fremeau R; Huang X; Ilch C; Kornecook TJ; Kreiman C; Ligutti J; Jasmine Lin MH; McDermott JS; Marx I; Matson DJ; McDonough SI; Moyer BD; Nho Nguyen H; Taborn K; Yu V; Weiss MM
    Bioorg Med Chem Lett; 2017 Aug; 27(15):3477-3485. PubMed ID: 28629594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human Mendelian pain disorders: a key to discovery and validation of novel analgesics.
    Goldberg YP; Pimstone SN; Namdari R; Price N; Cohen C; Sherrington RP; Hayden MR
    Clin Genet; 2012 Oct; 82(4):367-73. PubMed ID: 22845492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.